Skip to content

Abbott India Analysis


Update on Pharma Funds investment status. Stops have not moved while NAV’s dropped. The risk remains at 2%. UTI Pharma has done well among the peers. How a small deviation in the holdings helps Mutual Fund Schemes to outperform and will such trend continue? Which funds have the holdings of upcoming stocks? Only DSP having most of the stocks is a surprise.

Abbott is in a long term bullish trend while going into a short term correction. Those holding the stock can exit now and buy later.

Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on whatsapp
Share on email

Book An Enquiry